Amir Weiss insider trades

Open-market stock purchases and sales by Amir Weiss, Chief Accounting Officer at Teva Pharmaceutical Industries Ltd, from SEC Form 4 filings since Feb 28, 2022.

Recent trades

DateStockTradeValue
Aug 21, 2026TEVA Teva Pharmaceutical Industries LtdSold$261K
Aug 21, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)$49K
Aug 21, 2026TEVA Teva Pharmaceutical Industries LtdSold$94.1K
Aug 21, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)$47.9K
May 6, 2026TEVA Teva Pharmaceutical Industries LtdSold$384K
Mar 5, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 4, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Mar 3, 2026TEVA Teva Pharmaceutical Industries LtdBought (not open market)—
Dec 16, 2025TEVA Teva Pharmaceutical Industries LtdSold$372K
Nov 6, 2025TEVA Teva Pharmaceutical Industries LtdSold$301K

Companies traded

  • TEVA Teva Pharmaceutical Industries Ltd: 9 sales, last Aug 21, 2026

Get free alerts when Amir Weiss files a new trade →